PTEN and cervical carcinoma: PTEN is mutated in 2.6% of amplified cancers and in 8.6% of non-amplified cancers, while TP53 shows no mutations in 3q26-amplified cancers and is mutated in 7.7% of non-amplified cervical cancers.